Having established that DRP-1 acts mostly in apoptosis to impact muscle degeneration upon dystrophin deficiency, it would be interesting to investigate whether others molecular mechanisms than cleavage by caspase-3 can regulate DRP-1 activity94. The gene discussed is CASP3; the disease is neuromuscular disease caused by qualitative or quantitative defects of dystrophin.